Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Contract

27 Jun 2011 07:00

RNS Number : 1079J
Bioquell PLC
27 June 2011
 



 

 

27 June, 2011

 

 

BIOQUELL PLC

Completion of the registration of Bioquell China

Award of c. US$ 1 million contract for specialist bio-decontamination equipment to be used by the Chinese Ministry of Agriculture

 

Bioquell PLC (LSE: BQE) ("Bioquell") - provider of specialist low temperature, residue-free bio-decontamination technologies to the healthcare, life sciences and defence sectors - announces that the Chinese authorities have completed the approvals necessary for the registration of Bioquell China.

In addition, Bioquell announces that it has been awarded a contract to supply specialist hydrogen peroxide vapour bio-decontamination equipment to research organisations within the Chinese Government's Ministry of Agriculture worth approximately US$1 million. This bio-decontamination equipment is scheduled to be shipped in the second half of the year - and will be installed and serviced by Bioquell China.

 

Commenting on this contract award in China, Nick Adams, Group Chief Executive of Bioquell PLC, said:

"We are delighted to have won a significant first contract for our unique hydrogen peroxide vapour bio-decontamination equipment from Chinese government research organisations."

"This contract award helps demonstrate the benefits of our substantial investment in the Asia Pacific region - and specifically the establishment of Bioquell China."

 

- Ends -

 

 

Enquiries:

 

Bioquell PLC 01264 835 900

Nick Adams Group Chief Executive

Mark Bodeker Chief Operating Officer / Finance Director

 

Notes to editors:

§ Bioquell is a UK-headquartered, international technology company with two divisions:

o Bio-decontamination which sells specialist bio-decontamination products and services into the Healthcare, Life Sciences and Defence sectors, with most of its revenues generated from overseas customers; and

o TRaC which provides UK corporates with specialist Testing, Regulatory and Compliance services - many of which are required by national and international regulations.

§ Bioquell's gas phase bio-decontamination technology uses hydrogen peroxide vapour - which is highly efficacious at eradicating micro-organisms such as bacteria, viruses and fungi at room temperature - and is subsequently broken down using specialist catalysts to water vapour and oxygen at the end of the bio-decontamination process.

§ Bioquell's bio-decontamination technology:

o is used by bio-pharmaceutical, biologics, biotechnology and research institutions to provide sterile equipment and/or sterile working environments - which is of particular interest to organisations working with biologically-derived drugs;

o is also used by researchers involved in the study of zoonotic transfer whereby diseases in animals can be transferred to humans - with examples including SARS (which is believed to have originated in China) and porcine swine fever (which originated in Mexico)

o is used to eradicate drug resistant organisms associated with Hospital Acquired Infection as well as problematic viruses from the hospital environment. Independent scientific research has demonstrated that 'bioquelling' hospital equipment and facilities reduces the rates of hospital acquired infection;

o was selected by the United States Department of Defense for the JSSED programme to decontaminate sensitive equipment against biological and chemical warfare agents;

o benefits from a number of granted or pending patent filings in the UK and internationally;

o is used in other sectors where bioburden can create significant problems including, for example, the food industry; and

o also comprises specialist filtration technology including peroxide catalysis and chemical, biological, radiological and nuclear ("CBRN") filtration systems used principally in the defence sector.

§ Bioquell currently has overseas operations in the USA, France, Ireland, Singapore and China.

§ TRaC sells its specialist testing services to the product development and engineering departments of a broad range of companies and organisations, principally based in the UK, with a particular focus on the aerospace, military and telecoms sectors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSESFILFFSESM
Date   Source Headline
17th Jun 20169:36 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
16th Jun 20164:15 pmRNSRule 2.10 Announcement
15th Jun 20168:59 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
14th Jun 20168:42 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
13th Jun 20169:05 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
10th Jun 20162:41 pmRNSResult of AGM
10th Jun 20168:40 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
9th Jun 20168:34 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
8th Jun 20163:14 pmRNSDirectorate Change
8th Jun 20169:07 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
7th Jun 20168:52 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
6th Jun 20169:47 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
3rd Jun 20169:25 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
2nd Jun 20167:00 amRNSTender Offer
1st Jun 20169:18 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
31st May 20168:37 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
27th May 20168:44 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
26th May 20168:44 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
25th May 20168:57 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
24th May 20164:38 pmRNSRule 2.10 Announcement
24th May 20168:51 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
23rd May 20169:21 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
20th May 20168:41 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
19th May 20168:45 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
18th May 20168:52 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
17th May 20169:01 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
16th May 201610:10 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
13th May 20165:36 pmRNSFurther re Annual Report
13th May 201610:00 amRNSRule 2.10 Announcement
13th May 20169:20 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
12th May 20169:27 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
11th May 20169:09 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
10th May 20169:34 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
9th May 20161:05 pmRNSRule 2.10 Announcement
9th May 201610:10 amRNSForm 8.5 (EPT/RI) Bioquell Plc
6th May 201610:24 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
6th May 20168:18 amRNSBlock listing Interim Review
5th May 201610:07 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
4th May 20164:29 pmRNSRule 2.10 Announcement
4th May 201610:00 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
3rd May 201610:43 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
29th Apr 20163:52 pmRNSStatement re Annual Report
29th Apr 20169:31 amRNSForm 8.5 (EPT/RI) - Bioquell
29th Apr 20167:00 amRNSAnnual Financial Report
29th Apr 20167:00 amRNSTender Offer
27th Apr 20169:52 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
25th Apr 20169:58 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
22nd Apr 20169:11 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
21st Apr 20168:51 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
20th Apr 201610:00 amRNSForm 8.5 (EPT/RI) - Bioquell Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.